Mon, 24 Nov 2014 13:25:06 GMT ~ IGI Laboratories, Inc. Announces ANDA Submission
[at noodls] - BUENA, N.J. , Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted an additional abbreviated ...
Mon, 24 Nov 2014 13:00:00 GMT ~ IGI Laboratories, Inc. Announces ANDA Submission
[PR Newswire] - BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted an additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions in 2014 to seven, with eighteen submissions now pending at the FDA. Jason Grenfell-Gardner, President and CEO of the Company, commented, "Our team here at IGI has continued to deliver on the development front. We now have eighteen ANDAs pending approval and on file with the FDA, in addition to four more ANDAs pending approval under joint development agreements with our partners. This should be the first of several ANDAs we file in this quarter, as we plan to file another three to four ANDAs before the end of 2014.
Link: http://www.otcmarkets.com/stock/IG/company-info Ticker: $IG OTC Market Place: Not Available CIK code: 0000352998 Company name: IGI, Laboratories, Inc. Incorporated In: DE, USA
$IG share structure
## source: otcmarkets.com
Market Value: $552,688,130 a/o Nov 28, 2014 Shares Outstanding: 52,787,787 a/o Nov 06, 2014 Float: Not Available Authorized Shares: Not Available Par Value: 0.01 $IG extra dd links